De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
UPR Overzicht aandelen
Uniphar plc is als gediversifieerd bedrijf actief in de gezondheidszorg in de Republiek Ierland, het Verenigd Koninkrijk, Nederland en internationaal.
Sneeuwvlok Score | |
---|---|
Waardering | 4/6 |
Toekomstige groei | 3/6 |
Prestaties in het verleden | 2/6 |
Financiële gezondheid | 4/6 |
Dividenden | 0/6 |
Beloningen
Risicoanalyse
Uniphar plc Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | €2.53 |
52 Week Hoogtepunt | €3.00 |
52 Week Laag | €1.98 |
Bèta | 0.75 |
11 maand verandering | -2.88% |
3 maanden verandering | 3.70% |
1 Jaar Verandering | 14.25% |
33 jaar verandering | -40.59% |
5 jaar verandering | 112.18% |
Verandering sinds IPO | 115.81% |
Recent nieuws en updates
Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Recent updates
Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Rendement voor aandeelhouders
UPR | IE Healthcare | IE Markt | |
---|---|---|---|
7D | 3.5% | 1.2% | 1.4% |
1Y | 14.3% | 13.2% | 20.1% |
Rendement versus industrie: UPR overtrof de Irish Healthcare industrie, die het afgelopen jaar een rendement 12.9 % opleverde.
Rendement versus markt: UPR presteerde slechter dan Irish Market, dat het afgelopen jaar een rendement van 13 % opleverde.
Prijsvolatiliteit
UPR volatility | |
---|---|
UPR Average Weekly Movement | 4.1% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 4.0% |
10% most volatile stocks in IE Market | 6.8% |
10% least volatile stocks in IE Market | 2.2% |
Stabiele aandelenkoers: UPR heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van UPR is het afgelopen jaar stabiel geweest.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc is als gediversifieerd bedrijf actief in de gezondheidszorg in de Republiek Ierland, het Verenigd Koninkrijk, Nederland en internationaal. Het bedrijf is actief via drie divisies: Medtech, Pharma en Supply Chain & Retail. De divisie Medtech biedt uitbestede verkoop-, marketing-, distributie- en ondersteuningsdiensten aan fabrikanten van medische hulpmiddelen.
Uniphar plc Samenvatting
UPR fundamentele statistieken | |
---|---|
Marktkapitalisatie | €689.36m |
Inkomsten(TTM) | €45.17m |
Inkomsten(TTM) | €2.68b |
15.3x
Koers/Winstverhouding0.3x
P/S-verhoudingIs UPR overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
UPR resultatenrekening (TTM) | |
---|---|
Inkomsten | €2.68b |
Kosten van inkomsten | €2.27b |
Brutowinst | €408.69m |
Overige uitgaven | €363.52m |
Inkomsten | €45.17m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | 0.17 |
Brutomarge | 15.24% |
Nettowinstmarge | 1.68% |
Schuld/Eigen Vermogen Verhouding | 68.5% |
Hoe presteerde UPR op de lange termijn?
Bekijk historische prestaties en vergelijking